Advances in the design, generation, and application of tissue-engineered myocardial equivalents
Due to the limited regenerative ability of cardiomyocytes, the disabling irreversible condition of myocardial failure can only be treated with conservative and temporary therapeutic approaches, not able to repair the damage directly, or with organ transplantation. Among the regenerative strategies,...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2023-09-01
|
| Series: | Frontiers in Bioengineering and Biotechnology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fbioe.2023.1247572/full |
| _version_ | 1827809035755192320 |
|---|---|
| author | Giacomo Bernava Laura Iop |
| author_facet | Giacomo Bernava Laura Iop |
| author_sort | Giacomo Bernava |
| collection | DOAJ |
| description | Due to the limited regenerative ability of cardiomyocytes, the disabling irreversible condition of myocardial failure can only be treated with conservative and temporary therapeutic approaches, not able to repair the damage directly, or with organ transplantation. Among the regenerative strategies, intramyocardial cell injection or intravascular cell infusion should attenuate damage to the myocardium and reduce the risk of heart failure. However, these cell delivery-based therapies suffer from significant drawbacks and have a low success rate. Indeed, cardiac tissue engineering efforts are directed to repair, replace, and regenerate native myocardial tissue function. In a regenerative strategy, biomaterials and biomimetic stimuli play a key role in promoting cell adhesion, proliferation, differentiation, and neo-tissue formation. Thus, appropriate biochemical and biophysical cues should be combined with scaffolds emulating extracellular matrix in order to support cell growth and prompt favorable cardiac microenvironment and tissue regeneration. In this review, we provide an overview of recent developments that occurred in the biomimetic design and fabrication of cardiac scaffolds and patches. Furthermore, we sift in vitro and in situ strategies in several preclinical and clinical applications. Finally, we evaluate the possible use of bioengineered cardiac tissue equivalents as in vitro models for disease studies and drug tests. |
| first_indexed | 2024-03-11T22:36:42Z |
| format | Article |
| id | doaj.art-3603ca47443e4a2793cdb99165bfd63b |
| institution | Directory Open Access Journal |
| issn | 2296-4185 |
| language | English |
| last_indexed | 2024-03-11T22:36:42Z |
| publishDate | 2023-09-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Bioengineering and Biotechnology |
| spelling | doaj.art-3603ca47443e4a2793cdb99165bfd63b2023-09-22T12:30:07ZengFrontiers Media S.A.Frontiers in Bioengineering and Biotechnology2296-41852023-09-011110.3389/fbioe.2023.12475721247572Advances in the design, generation, and application of tissue-engineered myocardial equivalentsGiacomo BernavaLaura IopDue to the limited regenerative ability of cardiomyocytes, the disabling irreversible condition of myocardial failure can only be treated with conservative and temporary therapeutic approaches, not able to repair the damage directly, or with organ transplantation. Among the regenerative strategies, intramyocardial cell injection or intravascular cell infusion should attenuate damage to the myocardium and reduce the risk of heart failure. However, these cell delivery-based therapies suffer from significant drawbacks and have a low success rate. Indeed, cardiac tissue engineering efforts are directed to repair, replace, and regenerate native myocardial tissue function. In a regenerative strategy, biomaterials and biomimetic stimuli play a key role in promoting cell adhesion, proliferation, differentiation, and neo-tissue formation. Thus, appropriate biochemical and biophysical cues should be combined with scaffolds emulating extracellular matrix in order to support cell growth and prompt favorable cardiac microenvironment and tissue regeneration. In this review, we provide an overview of recent developments that occurred in the biomimetic design and fabrication of cardiac scaffolds and patches. Furthermore, we sift in vitro and in situ strategies in several preclinical and clinical applications. Finally, we evaluate the possible use of bioengineered cardiac tissue equivalents as in vitro models for disease studies and drug tests.https://www.frontiersin.org/articles/10.3389/fbioe.2023.1247572/fullcardiovascular diseasescardiac tissue engineeringmyocardiumdisease modelingregenerative medicine |
| spellingShingle | Giacomo Bernava Laura Iop Advances in the design, generation, and application of tissue-engineered myocardial equivalents Frontiers in Bioengineering and Biotechnology cardiovascular diseases cardiac tissue engineering myocardium disease modeling regenerative medicine |
| title | Advances in the design, generation, and application of tissue-engineered myocardial equivalents |
| title_full | Advances in the design, generation, and application of tissue-engineered myocardial equivalents |
| title_fullStr | Advances in the design, generation, and application of tissue-engineered myocardial equivalents |
| title_full_unstemmed | Advances in the design, generation, and application of tissue-engineered myocardial equivalents |
| title_short | Advances in the design, generation, and application of tissue-engineered myocardial equivalents |
| title_sort | advances in the design generation and application of tissue engineered myocardial equivalents |
| topic | cardiovascular diseases cardiac tissue engineering myocardium disease modeling regenerative medicine |
| url | https://www.frontiersin.org/articles/10.3389/fbioe.2023.1247572/full |
| work_keys_str_mv | AT giacomobernava advancesinthedesigngenerationandapplicationoftissueengineeredmyocardialequivalents AT lauraiop advancesinthedesigngenerationandapplicationoftissueengineeredmyocardialequivalents |